Koers Vcanbio Cell & Gene Engineering Corp., Ltd
Aandelen
600645
CNE000000545
Medische apparatuur, benodigdheden & distributie
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
16,26 CNY | +1,31% | -6,07% | -19,78% |
Omzet 2021 | 1,54 mld. 212 mln. 197 mln. | Omzet 2022 | 1,55 mld. 215 mln. 199 mln. | Marktkapitalisatie | 7,96 mld. 1,1 mld. 1,02 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | 155 mln. 21,45 mln. 19,86 mln. | Nettowinst (verlies) 2022 | 113 mln. 15,64 mln. 14,48 mln. | EV/omzet 2021 | 6,97 x |
Nettoliquiditeiten 2021 | 1,11 mld. 154 mln. 143 mln. | Nettoliquiditeiten 2022 | 1,25 mld. 173 mln. 160 mln. | EV/omzet 2022 | 4,31 x |
K/w-verhouding 2021 |
76,5
x | K/w-verhouding 2022 |
70,9
x | Werknemers | 2.332 |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 72,17% |
1 dag | +1,31% | ||
1 week | -6,07% | ||
Lopende maand | -2,58% | ||
1 maand | -3,39% | ||
3 maanden | -15,97% | ||
6 maanden | -11,29% | ||
Lopend jaar | -19,78% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yong Wang
CEO | Chief Executive Officer | 57 | 30-06-09 |
Xiao Ting Wang
DFI | Director of Finance/CFO | 42 | 25-05-22 |
Hai Bin Li
BRD | Director/Board Member | 53 | 01-02-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Hong Jia Gong
CHM | Chairman | 59 | 26-03-22 |
Yan Wang
CHM | Chairman | 53 | 16-05-23 |
Hong Qi Wang
BRD | Director/Board Member | 59 | 16-05-23 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 36 M€ | +4,88% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 16,26 | +1,31% | 4 323 600 |
27-03-24 | 16,05 | -1,71% | 4 658 700 |
26-03-24 | 16,33 | -1,03% | 4 284 102 |
25-03-24 | 16,5 | -2,19% | 4 823 882 |
22-03-24 | 16,87 | -2,32% | 5 403 100 |
slotkoers Shanghai S.E., 28 maart 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-19,78% | 1,04 mld. | |
-4,69% | 8,1 mld. | |
-3,69% | 5,13 mld. | |
-0,04% | 4,72 mld. | |
-32,31% | 4,4 mld. | |
-0,55% | 4,14 mld. | |
+15,50% | 2,82 mld. | |
+3,24% | 2,55 mld. | |
+12,54% | 1,92 mld. | |
+1,28% | 1,65 mld. |